Ergothioneine ameliorates metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) by enhancing autophagy, inhibiting oxidative damage and inflammation

Ergothioneine ameliorates metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) by enhancing autophagy, inhibiting oxidative damage and inflammation

Abstract Background Metabolic dysfunction-associated steatosis liver disease (MASLD) is one of the most common metabolic liver diseases around the world, whose prevalence continues to increase. Currently, there are few medications to treat MASLD. Ergothioneine is a natural compound derived from mush...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoyu Lv, Chenyu Nie, Yihan Shi, Qincheng Qiao, Jing Gao, Ying Zou, Jingwen Yang, Li Chen, Xinguo Hou
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Lipids in Health and Disease
Subjects:
Ergothioneine
MASLD
Autophagy
Lipid metabolism
Apoptosis
Oxidative stress
Online Access:https://doi.org/10.1186/s12944-024-02382-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12944-024-02382-9

Similar Items